Objectives <p>This study aims to explore the views of Pacific people on how to improve the management of urate-lowering therapy among Pacific gout patients in South Auckland.</p> Methods <p>The study used the Fa’afaletui model to explore the views on gout management across different perspectives of Pacific community members and health professionals working in health providers with high Pacific patient populations. Three workshops were delivered with the community and health professionals. All data were collected by note-takers and analysed using a general inductive approach. Participants were given the opportunity to review the results of the previous workshop before starting the next one.</p> Results <p>The key findings from this study clustered into three key themes: [<CitationRef CitationID="CR1">1</CitationRef>] Gout interventions guided by Pacific frameworks and research; [<CitationRef CitationID="CR2">2</CitationRef>] a multifaceted approach including education, improved access to treatment and screening for gout, and strategies to help Pacific gout patients remain engaged and adherent; and [<CitationRef CitationID="CR3">3</CitationRef>] Pacific gout champions.</p> Conclusion <p>This study presents the views of community members of how to improve the uptake of urate-lowering therapy among Pacific gout patients. The community highlighted the need for a multifaceted intervention governed by a Pacific model, addressing access barriers and education for Pacific gout patients.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Pacific community’s perceptions on how to improve uptake of urate-lowering therapy for Pacific gout patients

  • Samuela Ofanoa,
  • Malakai Ofanoa,
  • Siobhan Tu’akoi,
  • Hinamaha Lutui,
  • Maryann Heather,
  • Felicity Goodyear-Smith

摘要

Objectives

This study aims to explore the views of Pacific people on how to improve the management of urate-lowering therapy among Pacific gout patients in South Auckland.

Methods

The study used the Fa’afaletui model to explore the views on gout management across different perspectives of Pacific community members and health professionals working in health providers with high Pacific patient populations. Three workshops were delivered with the community and health professionals. All data were collected by note-takers and analysed using a general inductive approach. Participants were given the opportunity to review the results of the previous workshop before starting the next one.

Results

The key findings from this study clustered into three key themes: [1] Gout interventions guided by Pacific frameworks and research; [2] a multifaceted approach including education, improved access to treatment and screening for gout, and strategies to help Pacific gout patients remain engaged and adherent; and [3] Pacific gout champions.

Conclusion

This study presents the views of community members of how to improve the uptake of urate-lowering therapy among Pacific gout patients. The community highlighted the need for a multifaceted intervention governed by a Pacific model, addressing access barriers and education for Pacific gout patients.